Haemonetics Corporation (HAE)

NYSE

Currency in USD

HAE Pro Research

87.84

+2.82(+3.32%)

Closed·07/08

After Hours

87.840.00(0.00%)

·07/08

Fair Value

Unlock Value

Day's Range

84.88

87.87

52 wk Range

47.31

88.58

HAE Income Statement

Assess the Haemonetics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the HAE net worth.

Period Ending:

2017

01/04

2018

31/03

2019

30/03

2020

28/03

2021

03/04

2022

02/04

2023

01/04

2024

30/03

2025

29/03

2026

28/03

Total Revenues

aa.aa

993.2

1,168.66

1,309.06

1,360.82

1,334.03

Total Revenues Growth

aa.aa

+14.1%

+17.67%

+12.01%

+3.95%

-1.97%

Cost Of Revenues

aa.aa

462.43

545.79

600.49

582.28

541.16

Gross Profit

aa.aa

530.77

622.87

708.57

778.55

792.87

Gross Profit Growth

aa.aa

+23.88%

+17.35%

+13.76%

+9.88%

+1.84%

Gross Profit Margin %

aa.aa

53.44%

53.3%

54.13%

57.21%

59.43%

Other Operating Expenses, Total

aa.aa

425.6

455.67

503.08

531.45

541.34

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+29.62%	+7.07%	+10.4%	+5.64%	+1.86%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	45.98	49.08	52.23	61.13	58.8
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	332.2	373.95	418.82	422.05	438.54
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

105.17

167.2

205.49

247.1

251.53

Operating Income Growth

aa.aa

+5.07%

+58.98%

+22.9%

+20.25%

+1.79%

EBIT Margin %

aa.aa

10.59%

14.31%

15.7%

18.16%

18.86%

Net Interest Expenses

aa.aa

-5.8

-13

-19.5

-35.9

-19.3

Net Interest Expenses Growth

aa.aa

+38.3%

-124.14%

-50%

-84.1%

+46.24%

Interest Expense, Total

aa.aa

-5.8

-13

-19.5

-35.9

-19.3

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-11.32

-1.63

6.48

13.55

-14.3

EBT, Excl. Unusual Items

aa.aa

88.05

152.57

192.47

224.75

217.93

Gain (Loss) On Sale Of Assets

aa.aa

9.6

0.38

Other Unusual Items, Total

aa.aa

-5.2

-10.42

33.23

-84.67

EBT, Incl. Unusual Items

aa.aa

63.63

141.4

151.87

212.07

128.03

EBT, Incl. Unusual Items Growth

aa.aa

-12.73%

+122.23%

+7.4%

+39.64%

-39.63%

EBT, Incl. Unusual Items Margin

aa.aa

6.41%

12.1%

11.6%

15.58%

9.6%

Income Tax Expense

aa.aa

20.25

34.31

44.39

30.72

Net Income to Company

aa.aa

43.38

115.4

117.56

167.68

97.31

Minority Interest

aa.aa

Net Income

aa.aa

43.38

115.4

117.56

167.68

97.31

Net Income Growth

aa.aa

-45.42%

+166.05%

+1.87%

+42.64%

-41.97%

Net Income Margin %

aa.aa

4.37%

9.87%

8.98%

12.32%

7.29%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

43.38

115.4

117.56

167.68

97.31

Basic EPS - Continuing Operations

aa.aa

0.85

2.27

2.32

3.33

2.06

Basic EPS - Continuing Operations Growth

aa.aa

-45.8%

+167.44%

+2.02%

+43.7%

-38.09%

Diluted EPS - Continuing Operations

aa.aa

0.84

2.24

2.29

3.31

2.05

Diluted EPS - Continuing Operations Growth

aa.aa

-45.81%

+166.67%

+2.23%

+44.54%

-38.07%

Basic Weighted Average Shares Outstanding

aa.aa

51.05

50.78

50.71

50.33

47.18

Diluted Weighted Average Shares Outstanding

aa.aa

51.35

51.42

51.4

50.73

47.35

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

191.72

252.01

294.11

355.99

357.15

EBITDA Growth

aa.aa

+3.98%

+31.45%

+16.71%

+21.04%

+0.33%

EBITDA Margin %

aa.aa

19.3%

21.56%

22.47%

26.16%

26.77%

EBIT

aa.aa

105.17

167.2

205.49

247.1

251.53

* In Millions of USD (except for per share items)

FAQ

What was Haemonetics’s revenue at year end?

At the end of the last reported fiscal year, Haemonetics (HAE) recorded total revenue of 1,334.03 million USD.

How much revenue did Haemonetics report in the most recent quarter?

In its most recent quarterly earnings report, Haemonetics posted revenue of 339.38 million USD.

What was Haemonetics’s net income for the year?

For the full year, Haemonetics reported net income of 97.31 million USD.

How much net income did Haemonetics post in the last quarter?

In the most recent quarter, Haemonetics (HAE) posted net income of 33.01 million USD.

What was Haemonetics’s gross profit for the year?

Gross profit for the year was reported at 792.87 million USD.

How much gross profit did Haemonetics generate last quarter?

Haemonetics recorded gross profit of 203.59 million USD in its latest quarterly report.

What was Haemonetics’s annual operating income?

For the full year, Haemonetics (HAE) reported operating income of 251.53 million USD.

What was Haemonetics’s operating income last quarter?

Quarterly operating income was 60.86 million USD.

What was Haemonetics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 87.97 million USD.

What was the quarter-over-quarter change in EBITDA for Haemonetics?

EBITDA changed by 26.96% million USD compared to the last quarter.

What is Haemonetics’s most recent gross profit margin?

The latest reported gross profit margin for Haemonetics (HAE) is 59.99% million USD.

What is Haemonetics’s most recent net income margin?

Net income margin based on recent financials is 9.73% million USD.

What is Haemonetics’s most recent EBIT margin?

Haemonetics reported an EBIT margin of 17.93% million USD based on current figures.

How did Haemonetics’s revenue change compared to the previous quarter?

Revenue changed by -2.01% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Haemonetics?

In the latest quarter, gross profit changed by 2.69% million USD from the previous quarter.

S&P/TSX

36,381.23

+244.92

+0.68%

S&P/TSX 60

2,139.10

+7.23

+0.34%

US 30

54,015.90

+130.7

+0.24%

US 500

7,753.40

+43.4

+0.56%

S&P 500 VIX

14.90

-0.25

-1.65%

DAX

26,319.45

+179.32

+0.69%

Dollar Index

99.48

-0.330

-0.33%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.55	-1.17%	13.15M
RBC	294.59	-0.66%	2.65M
Bank of Montreal	253.24	-0.09%	2.59M
Shopify Inc	211.37	+2.40%	3.06M
Toronto Dominion Bank	169.30	-0.39%	3.79M
Suncor Energy	83.83	-2.57%	7.05M
Barrick Mining	60.96	+4.96%	8.30M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	692.50K
FuelPositive	0.070	+133.33%	2.26M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K
Digicann Ventures	0.010	+100.00%	2.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	692.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	10.15K
Big Bear Gold	0.07	-78.33%	15.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Albert Labs International	0.005	-50.00%	1.00K
Champion Electric	0.005	-50.00%	39.00K
International Iconic Gold Exploration	0.0050	-50.00%	276.00K
Red Lake Gold	0.0050	-50.00%	51.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	443.51	+0.19%	541.78K
TELUS	13.53	-1.60%	8.51M
Equinox Gold	16.16	+7.16%	7.24M
Alamos Gold	46.26	+6.00%	1.28M
BCE Inc	31.67	-0.63%	2.82M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa	2.860	+58.57%	4.535
A Aaaaaa Aaaaaaaaaaa	34.74	+55.48%	54.01
Aaaaaaaaa	104.38	+52.02%	158.68
Aaaaaaaaaaaaaaaaa	8.70	+48.66%	12.93
A A Aaa A	142.78	+46.11%	208.62
Aaaaa	5.31	+45.40%	7.72
Aaaaaa A	4.75	+41.65%	6.73

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa	2.860	+58.57%	4.535
A Aaaaaa Aaaaaaaaaaa	34.74	+55.48%	54.01
Aaaaaaaaa	104.38	+52.02%	158.68
Aaaaaaaaaaaaaaaaa	8.70	+48.66%	12.93
A A Aaa A	142.78	+46.11%	208.62
Aaaaa	5.31	+45.40%	7.72
Aaaaaa A	4.75	+41.65%	6.73

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Haemonetics Corporation (HAE)

HAE Income Statement

FAQ

What was Haemonetics’s revenue at year end?

How much revenue did Haemonetics report in the most recent quarter?

What was Haemonetics’s net income for the year?

How much net income did Haemonetics post in the last quarter?

What was Haemonetics’s gross profit for the year?

How much gross profit did Haemonetics generate last quarter?

What was Haemonetics’s annual operating income?

What was Haemonetics’s operating income last quarter?

What was Haemonetics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Haemonetics?

What is Haemonetics’s most recent gross profit margin?

What is Haemonetics’s most recent net income margin?

What is Haemonetics’s most recent EBIT margin?

How did Haemonetics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Haemonetics?

Trending Stocks